Eintrag weiter verarbeiten
Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population
Gespeichert in:
Zeitschriftentitel: | Bioscience Reports |
---|---|
Personen und Körperschaften: | , , , , , , |
In: | Bioscience Reports, 39, 2019, 7 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Portland Press Ltd.
|
Schlagwörter: |
author_facet |
Yang, Jing Liu, Jiaochun Chen, Yu Tang, Weifeng Bo, Kai Sun, Yuling Chen, Jianping Yang, Jing Liu, Jiaochun Chen, Yu Tang, Weifeng Bo, Kai Sun, Yuling Chen, Jianping |
---|---|
author |
Yang, Jing Liu, Jiaochun Chen, Yu Tang, Weifeng Bo, Kai Sun, Yuling Chen, Jianping |
spellingShingle |
Yang, Jing Liu, Jiaochun Chen, Yu Tang, Weifeng Bo, Kai Sun, Yuling Chen, Jianping Bioscience Reports Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population Cell Biology Molecular Biology Biochemistry Biophysics |
author_sort |
yang, jing |
spelling |
Yang, Jing Liu, Jiaochun Chen, Yu Tang, Weifeng Bo, Kai Sun, Yuling Chen, Jianping 0144-8463 1573-4935 Portland Press Ltd. Cell Biology Molecular Biology Biochemistry Biophysics http://dx.doi.org/10.1042/bsr20181824 <jats:title>Abstract</jats:title> <jats:p>Single nucleotide polymorphisms (SNPs) in immune related gene may influence the susceptibility of cancer. We selected inducible T cell costimulator (ICOS) rs4404254 T&gt;C, rs10932029 T&gt;C, CD28 rs3116496 T&gt;C and CD80 rs7628626 C&gt;A SNPs and assessed the potential relationship of these SNPs with hepatocellular carcinoma (HCC) risk. A total of 584 HCC cases and 923 healthy controls were recruited. And SNPscan™ genotyping assay was used to obtain the genotypes of ICOS, CD28 and CD80 polymorphisms. We found that ICOS rs10932029 T&gt;C polymorphism significantly increased the risk of HCC (additive model: adjusted odds ratio (OR), 1.59; 95% confidence interval (CI), 1.13–2.22; P=0.007; homozygote model: adjusted OR, 1.12; 95% CI, 0.31–4.03; P=0.867; dominant model: adjusted OR, 1.58; 95% CI, 1.14–2.19; P=0.007 and recessive model: adjusted OR, 1.02; 95% CI, 0.28–3.68; P=0.974). However, ICOS rs4404254 T&gt;C, CD28 rs3116496 T&gt;C and CD80 rs7628626 C&gt;A SNPs were not associated with the risk of HCC. To evaluate the effects of ICOS rs10932029 T&gt;C on HCC risk according to different age, gender, chronic hepatitis B virus (HBV) infection, tobacco consumption and drinking status, we carried out a stratification analysis. We found that ICOS rs10932029 T&gt;C polymorphism might increase the risk of HCC in male, ≥53 years, never smoking, never drinking and non-chronic HBV infection subgroups. Our study highlights that ICOS rs10932029 T&gt;C polymorphism may confer the susceptibility to HCC. It may be beneficial to explore the relationship between variants in immune related genes and the development of HCC.</jats:p> Investigation of <i>ICOS, CD28</i> and <i>CD80</i> polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population Bioscience Reports |
doi_str_mv |
10.1042/bsr20181824 |
facet_avail |
Online Free |
finc_class_facet |
Biologie Chemie und Pharmazie Physik |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Mi9ic3IyMDE4MTgyNA |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Mi9ic3IyMDE4MTgyNA |
institution |
DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 |
imprint |
Portland Press Ltd., 2019 |
imprint_str_mv |
Portland Press Ltd., 2019 |
issn |
0144-8463 1573-4935 |
issn_str_mv |
0144-8463 1573-4935 |
language |
English |
mega_collection |
Portland Press Ltd. (CrossRef) |
match_str |
yang2019investigationoficoscd28andcd80polymorphismswiththeriskofhepatocellularcarcinomaacasecontrolstudyineasternchinesepopulation |
publishDateSort |
2019 |
publisher |
Portland Press Ltd. |
recordtype |
ai |
record_format |
ai |
series |
Bioscience Reports |
source_id |
49 |
title |
Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population |
title_unstemmed |
Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population |
title_full |
Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population |
title_fullStr |
Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population |
title_full_unstemmed |
Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population |
title_short |
Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population |
title_sort |
investigation of <i>icos, cd28</i> and <i>cd80</i> polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern chinese population |
topic |
Cell Biology Molecular Biology Biochemistry Biophysics |
url |
http://dx.doi.org/10.1042/bsr20181824 |
publishDate |
2019 |
physical |
|
description |
<jats:title>Abstract</jats:title>
<jats:p>Single nucleotide polymorphisms (SNPs) in immune related gene may influence the susceptibility of cancer. We selected inducible T cell costimulator (ICOS) rs4404254 T&gt;C, rs10932029 T&gt;C, CD28 rs3116496 T&gt;C and CD80 rs7628626 C&gt;A SNPs and assessed the potential relationship of these SNPs with hepatocellular carcinoma (HCC) risk. A total of 584 HCC cases and 923 healthy controls were recruited. And SNPscan™ genotyping assay was used to obtain the genotypes of ICOS, CD28 and CD80 polymorphisms. We found that ICOS rs10932029 T&gt;C polymorphism significantly increased the risk of HCC (additive model: adjusted odds ratio (OR), 1.59; 95% confidence interval (CI), 1.13–2.22; P=0.007; homozygote model: adjusted OR, 1.12; 95% CI, 0.31–4.03; P=0.867; dominant model: adjusted OR, 1.58; 95% CI, 1.14–2.19; P=0.007 and recessive model: adjusted OR, 1.02; 95% CI, 0.28–3.68; P=0.974). However, ICOS rs4404254 T&gt;C, CD28 rs3116496 T&gt;C and CD80 rs7628626 C&gt;A SNPs were not associated with the risk of HCC. To evaluate the effects of ICOS rs10932029 T&gt;C on HCC risk according to different age, gender, chronic hepatitis B virus (HBV) infection, tobacco consumption and drinking status, we carried out a stratification analysis. We found that ICOS rs10932029 T&gt;C polymorphism might increase the risk of HCC in male, ≥53 years, never smoking, never drinking and non-chronic HBV infection subgroups. Our study highlights that ICOS rs10932029 T&gt;C polymorphism may confer the susceptibility to HCC. It may be beneficial to explore the relationship between variants in immune related genes and the development of HCC.</jats:p> |
container_issue |
7 |
container_start_page |
0 |
container_title |
Bioscience Reports |
container_volume |
39 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792330374333857795 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T13:23:38.16Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Investigation+of+ICOS%2C+CD28+and+CD80+polymorphisms+with+the+risk+of+hepatocellular+carcinoma%3A+a+case%E2%80%93control+study+in+eastern+Chinese+population&rft.date=2019-07-31&genre=article&issn=1573-4935&volume=39&issue=7&jtitle=Bioscience+Reports&atitle=Investigation+of+%3Ci%3EICOS%2C+CD28%3C%2Fi%3E+and+%3Ci%3ECD80%3C%2Fi%3E+polymorphisms+with+the+risk+of+hepatocellular+carcinoma%3A+a+case%E2%80%93control+study+in+eastern+Chinese+population&aulast=Chen&aufirst=Jianping&rft_id=info%3Adoi%2F10.1042%2Fbsr20181824&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792330374333857795 |
author | Yang, Jing, Liu, Jiaochun, Chen, Yu, Tang, Weifeng, Bo, Kai, Sun, Yuling, Chen, Jianping |
author_facet | Yang, Jing, Liu, Jiaochun, Chen, Yu, Tang, Weifeng, Bo, Kai, Sun, Yuling, Chen, Jianping, Yang, Jing, Liu, Jiaochun, Chen, Yu, Tang, Weifeng, Bo, Kai, Sun, Yuling, Chen, Jianping |
author_sort | yang, jing |
container_issue | 7 |
container_start_page | 0 |
container_title | Bioscience Reports |
container_volume | 39 |
description | <jats:title>Abstract</jats:title> <jats:p>Single nucleotide polymorphisms (SNPs) in immune related gene may influence the susceptibility of cancer. We selected inducible T cell costimulator (ICOS) rs4404254 T&gt;C, rs10932029 T&gt;C, CD28 rs3116496 T&gt;C and CD80 rs7628626 C&gt;A SNPs and assessed the potential relationship of these SNPs with hepatocellular carcinoma (HCC) risk. A total of 584 HCC cases and 923 healthy controls were recruited. And SNPscan™ genotyping assay was used to obtain the genotypes of ICOS, CD28 and CD80 polymorphisms. We found that ICOS rs10932029 T&gt;C polymorphism significantly increased the risk of HCC (additive model: adjusted odds ratio (OR), 1.59; 95% confidence interval (CI), 1.13–2.22; P=0.007; homozygote model: adjusted OR, 1.12; 95% CI, 0.31–4.03; P=0.867; dominant model: adjusted OR, 1.58; 95% CI, 1.14–2.19; P=0.007 and recessive model: adjusted OR, 1.02; 95% CI, 0.28–3.68; P=0.974). However, ICOS rs4404254 T&gt;C, CD28 rs3116496 T&gt;C and CD80 rs7628626 C&gt;A SNPs were not associated with the risk of HCC. To evaluate the effects of ICOS rs10932029 T&gt;C on HCC risk according to different age, gender, chronic hepatitis B virus (HBV) infection, tobacco consumption and drinking status, we carried out a stratification analysis. We found that ICOS rs10932029 T&gt;C polymorphism might increase the risk of HCC in male, ≥53 years, never smoking, never drinking and non-chronic HBV infection subgroups. Our study highlights that ICOS rs10932029 T&gt;C polymorphism may confer the susceptibility to HCC. It may be beneficial to explore the relationship between variants in immune related genes and the development of HCC.</jats:p> |
doi_str_mv | 10.1042/bsr20181824 |
facet_avail | Online, Free |
finc_class_facet | Biologie, Chemie und Pharmazie, Physik |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Mi9ic3IyMDE4MTgyNA |
imprint | Portland Press Ltd., 2019 |
imprint_str_mv | Portland Press Ltd., 2019 |
institution | DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1 |
issn | 0144-8463, 1573-4935 |
issn_str_mv | 0144-8463, 1573-4935 |
language | English |
last_indexed | 2024-03-01T13:23:38.16Z |
match_str | yang2019investigationoficoscd28andcd80polymorphismswiththeriskofhepatocellularcarcinomaacasecontrolstudyineasternchinesepopulation |
mega_collection | Portland Press Ltd. (CrossRef) |
physical | |
publishDate | 2019 |
publishDateSort | 2019 |
publisher | Portland Press Ltd. |
record_format | ai |
recordtype | ai |
series | Bioscience Reports |
source_id | 49 |
spelling | Yang, Jing Liu, Jiaochun Chen, Yu Tang, Weifeng Bo, Kai Sun, Yuling Chen, Jianping 0144-8463 1573-4935 Portland Press Ltd. Cell Biology Molecular Biology Biochemistry Biophysics http://dx.doi.org/10.1042/bsr20181824 <jats:title>Abstract</jats:title> <jats:p>Single nucleotide polymorphisms (SNPs) in immune related gene may influence the susceptibility of cancer. We selected inducible T cell costimulator (ICOS) rs4404254 T&gt;C, rs10932029 T&gt;C, CD28 rs3116496 T&gt;C and CD80 rs7628626 C&gt;A SNPs and assessed the potential relationship of these SNPs with hepatocellular carcinoma (HCC) risk. A total of 584 HCC cases and 923 healthy controls were recruited. And SNPscan™ genotyping assay was used to obtain the genotypes of ICOS, CD28 and CD80 polymorphisms. We found that ICOS rs10932029 T&gt;C polymorphism significantly increased the risk of HCC (additive model: adjusted odds ratio (OR), 1.59; 95% confidence interval (CI), 1.13–2.22; P=0.007; homozygote model: adjusted OR, 1.12; 95% CI, 0.31–4.03; P=0.867; dominant model: adjusted OR, 1.58; 95% CI, 1.14–2.19; P=0.007 and recessive model: adjusted OR, 1.02; 95% CI, 0.28–3.68; P=0.974). However, ICOS rs4404254 T&gt;C, CD28 rs3116496 T&gt;C and CD80 rs7628626 C&gt;A SNPs were not associated with the risk of HCC. To evaluate the effects of ICOS rs10932029 T&gt;C on HCC risk according to different age, gender, chronic hepatitis B virus (HBV) infection, tobacco consumption and drinking status, we carried out a stratification analysis. We found that ICOS rs10932029 T&gt;C polymorphism might increase the risk of HCC in male, ≥53 years, never smoking, never drinking and non-chronic HBV infection subgroups. Our study highlights that ICOS rs10932029 T&gt;C polymorphism may confer the susceptibility to HCC. It may be beneficial to explore the relationship between variants in immune related genes and the development of HCC.</jats:p> Investigation of <i>ICOS, CD28</i> and <i>CD80</i> polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population Bioscience Reports |
spellingShingle | Yang, Jing, Liu, Jiaochun, Chen, Yu, Tang, Weifeng, Bo, Kai, Sun, Yuling, Chen, Jianping, Bioscience Reports, Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population, Cell Biology, Molecular Biology, Biochemistry, Biophysics |
title | Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population |
title_full | Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population |
title_fullStr | Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population |
title_full_unstemmed | Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population |
title_short | Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population |
title_sort | investigation of <i>icos, cd28</i> and <i>cd80</i> polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern chinese population |
title_unstemmed | Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population |
topic | Cell Biology, Molecular Biology, Biochemistry, Biophysics |
url | http://dx.doi.org/10.1042/bsr20181824 |